Atomwise Stock (ATOW) Atomwise develops artificial intelligence systems using powerful deep learning algorithms and supercomputers for drug discovery.

Atomwise raises $123 million to accelerate drug discovery with AI. Atomwise, a company leveraging AI and machine learning to accelerate drug discovery, has ...

Information on valuation, funding, cap tables, investors, and executives for Atomwise. Use the PitchBook Platform to explore the full profile.

We are dedicated to developing the best AI platform and using it to transform small molecule drug discovery.

See Atomwise funding rounds, investors, investments, exits and more. Evaluate their financials based on Atomwise's post-money valuation and revenue.

Atomwise is a privately held company and is not publicly traded, therefore investing in Atomwise pre-IPO is only available to accredited investors. If you meet ...

Since its inception, Atomwise has made significant strides in the biotechnology industry, raising a total of $176.42 million in funding. This substantial ...

Company profile page for Atomwise Inc including stock price, company news, executives, board members, and contact information.

Featured News: Sanofi signs $1.2B pact with Atomwise in latest high-value AI drug discovery deal. Date: August 17, 2022. Source: Fierce Biotech.

12 окт. 2024 г. · Overall, Atomwise and its competitors have raised over $1.08B in funding across 25 funding rounds involving 109 investors. There is 1 public ...